January 20, 2010 - First Coast Oncology in Jacksonville, Fla., employs a technique for whole breast irradiation that is designed to target and deliver a boost dose accurately and reliably to the lumpectomy cavity margin.

The center aims to significantly enhance its ability to treat breast cancer with the addition of a Naviscan PEM (Positron Emission Mammography) scanner in conjunction with AccuBoost system for irradiation.  The facility will be among the first in the nation to use both a PEM scanner and the image-guided breast irradiation procedure to optimize their therapy treatment.

With PEM's three-dimensional metabolic perspective, physicians can visualize the region of interest prior to delivering the radiation system. The system is designed to lower dose to healthy tissue as radiation is focused on the intended target sparing exposure to the heart, lungs and the uninvolved breast.

"For more than 10 years, First Coast Oncology has provided the highest level of care to the women in Northeast Florida and Southeast Georgia who have been diagnosed with breast cancer," said Scot Ackerman, M.D., medical director of First Coast Oncology. "The acquisition of the Naviscan PEM scanner demonstrates First Coast Oncology's commitment to securing the latest technology to detect and treat breast cancer as well as being able to assess response to therapy. I expect that PEM will prove indispensable in the effective management of breast cancer for both our patients and referring physicians."

The Naviscan PEM scanner uses PET (Positron Emission Tomography) technology to produce high-resolution tomographic images at 2-millimeter resolution, allowing physicians to visualize breast tumors about the size of a grain of rice. The scanner is the size of a mammography unit and consists of two high-resolution detector heads, which are placed in close proximity to the breast. Compared to the higher-force compression necessary for mammography, the Naviscan PEM scanner uses gentle breast immobilization.

For more information: www.naviscan.com


Related Content

News | Radiopharmaceuticals and Tracers

Oct. 5, 2026 — GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a U.S.-based CMO for PET ...

Time October 06, 2026
arrow
News | PET-MRI

Sept. 29, 2026 —Yale New Haven Hospital has installed a state-of-the-art positron emission tomography/magnetic resonance ...

Time October 05, 2026
arrow
News | Stereotactic Body Radiation Therapy (SBRT)

Sept. 27, 2026 — Siemens Healthineers recently launched Accela, a radiotherapy solution engineered around NeoArc ...

Time October 01, 2026
arrow
News | Ultrasound Women's Health

Sept. 29, 2026 — A research team at the University of Virginia (UVA) led by Timothy Bullock, PhD, has published results ...

Time September 30, 2026
arrow
News | ASTRO

Sept. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has named Siemens Healthineers the inaugural ...

Time September 29, 2026
arrow
News | Proton Therapy

Sept. 28, 2026 — Penn Medicine and Ion Beam Applications (IBA) have formed Noventra Oncology Alliance, a new joint ...

Time September 28, 2026
arrow
News | ASTRO

Sept. 22, 2026 — Leading experts in radiation therapy from the Abramson Cancer Center (ACC) of the University of ...

Time September 24, 2026
arrow
News | ASTRO

Sept.16, 2026 — For appropriately selected patients with muscle-invasive bladder cancer, preserving the bladder can be a ...

Time September 17, 2026
arrow
News | Radiology Imaging

Sept. 1, 2026 — Leo Cancer Care and GE HealthCare have announced that the two companies intend to work together on GE ...

Time September 11, 2026
arrow
News | ASTRO

Sept. 9, 2026 — The 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, will take place Sept. 26 to 30 ...

Time September 11, 2026
arrow
Subscribe Now